Intradermal air pouch leukocytosis as an in vivo test for nanoparticles

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 4745-4755

  Vandooren, Jennifer ^a   Berghmans, Nele ^a   Dillen, Chris ^a   Van Aelst, Ilse ^a   Ronsse, Isabelle ^a   Israel, Liron Limor ^b   Rosenberger, Ina ^c   Kreuter, Jörg ^c   Lellouche, Jean Paul ^b   Michaeli, Shulamit ^b   Locatelli, Erica ^d   Franchini, Mauro Comes ^d   Aiertza, Miren K ^e   Sánchez Abella, Laura ^e   Loinaz, Iraida ^e   Edwards, Dylan R ^f   Shenkman, Louis ^g   Opdenakker, Ghislain ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b BAR ILAN UNIVERSITY   (Israel)

^c GOETHE UNIVERSITY   (Germany)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e Centro de Investigacion Tecnologica En Electroquimica   (Spain)

^f UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^g TEL AVIV UNIVERSITY   (Israel)

Author keywords

Air pouch; Biocompatibility; Immunology; Nanoparticles; Toxicity

Indexed keywords

GELATINASE B; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CHEMICAL COMPOSITION; CONTROLLED STUDY; ENZYME SYNTHESIS; IMMUNOCOMPETENT CELL; IMMUNOTOXICITY; IN VIVO STUDY; LEUKOCYTOSIS; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PARTICLE SIZE; QUALITY CONTROL; TOXICITY TESTING;

MUS;

AIR POUCH; BIOCOMPATIBILITY; IMMUNOLOGY; NANOPARTICLES; TOXICITY;

AIR; ANIMALS; BIOLOGICAL ASSAY; LEUKOCYTOSIS; MATERIALS TESTING; MICE; NANOPARTICLES; PARTICLE SIZE; POLYSTYRENES; TOXICITY TESTS;

EID: 84890341671     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S51628     Document Type: Article

References (43)

1. Seyle H. Effect of inflammation upon the growth of transplantable neoplasms as demonstrated by the double granuloma-pouch technique. Br J Cancer. 1957;11(4):550-553.
2. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-674.
3. Taylor PE, Tejada C, Sanchez M. The effect of malnutrition on the inflammatory response as exhibited by the granuloma pouch of the rat. J Exp Med. 1967;126(4):539-556.
4. Folkman J, Merler E, Abernathy C, Williams G. Isolation of a tumor factor responsible for angiogenesis. J Exp Med. 1971;133(2):275-288.
5. Okudaira M, Schwarz J. Histoplasma capsulatum infection in rat air pouch. Arch Pathol. 1962;74:239-243.
6. Sedgwick AD, Sin YM, Edwards JC, Willoughby DA. Increased inflammatory reactivity in newly formed lining tissue. J Pathol. 1983; 141(4):483-495.
7. Dalhoff A, Frank G, Luckhaus G. The granuloma pouch: an in vivo model for pharmacokinetic and chemotherapeutic investigations. I. Biochemical and histological characterization. Infection. 1982; 10(6):354-360.
8. Konno S, Tsurufuji S. Induction of zymosan-air-pouch inflammation in rats and its characterization with reference to the effects of anticomplementary and anti-inflammatory agents. Br J Pharmacol. 1983;80(2):269-277.
9. Sedgwick AD, Lees P. A comparison of air pouch, sponge and pleurisy models of acute carrageenan inflammation in the rat. Agents Actions. 1986;18(3-4):439-446.
10. Balasubramaniam GS, Hurley JV. The structure and reactions of the microcirculation in a subcutaneous air pouch in the rat. J Pathol. 1987; 151(2):139-146.
11. Hambleton P, Miller P. Studies on immunological air pouch inflammation in the rat. Int Arch Allergy Appl Immunol. 1988;87(1):70-75.
12. Francis DJ, Forrest MJ, Brooks PM, Ghosh P. Retardation of articular cartilage degradation by glycosaminoglycan polysulfate, pentosan polysulfate, and DH-40J in the rat air pouch model. Arthritis Rheum. 1989;32(5):608-616.
13. Isaji M, Momose Y, Naito J. Enhancement of inflammatory reactions in a non-immunological air pouch model in rats. Br J Exp Pathol. 1989;70(6):705-716.
14. Hashida R, Chiba K, Yamatsu I, Katayama K. Collagenase production in the exudate of a novel adjuvant-induced air pouch inflammation model in rats. Agents Actions. 1991;34(1-2):242-243.
15. Dawson J, Sedgwick AD, Edwards JC, Lees P. A comparative study of the cellular, exudative and histological responses to carrageenan, dextran and zymosan in the mouse. Int J Tissue React. 1991;13: 171-185.
16. Cronstein BN, Naime D, Ostad E. The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J Clin Invest. 1993;92(6):2675-2682.
17. Vane JR, Mitchell JA, Appleton I, etal. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci. U S A. 1994;91(6):2046-2050.
18. Masferrer JL, Zweifel BS, Manning PT, etal. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci U S A. 1994;91(8):3228-3232.
19. Martin SW, Stevens AJ, Brennan BS, etal. Regional drug delivery I: permeability characteristics of the rat 6-day-old air pouch model of inflammation. Pharm Res. 1995;12(12):1980-1986.
20. Appleton I, Brown NJ, Willis D, etal. The role of vascular endothelial growth factor in a murine chronic granulomatous tissue air pouch model of angiogenesis. J Pathol. 1996;180(1):90-94.
21. Romano M, Faggioni R, Sironi M, etal. Carrageenan-induced acute inflammation in the mouse air pouch synovial model. Role of tumour necrosis factor. Mediators Inflamm. 1997;6(1):32-38.
22. Terkeltaub R, Baird S, Sears P, Santiago R, Boisvert W. The murine homolog of the interleukin-8 receptor CXCR-2 is essential for the occurrence of neutrophilic inflammation in the air pouch model of acute urate crystal-induced gouty synovitis. Arthritis Rheum. 1998;41(5): 900-909.
23. Smith CJ, Zhang Y, Koboldt CM, etal. Pharmacological analysis of cyclooxygenase-1in inflammation. Proc Natl Acad Sci U S A. 1998; 95(22):13313-13318.
24. Fernandez AA, Cavalcanti F, Miralles A, etal. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid. Mol Pharmacol. 1999;55(4):753-760.
25. Cronstein BN, Montesinos MC, Weissmann G. Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB. Proc Natl Acad Sci U S A. 1999;96(11):6377-6381.
26. Bertini R, Howard OM, Dong HF, etal. Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells. J Exp Med. 1999; 189(11):1783-1789.
27. Hooper KA, Nickolas TL, Yurkow EJ, Kohn J, Laskin DL. Characterization of the inflammatory response to biomaterials using a rodent air pouch model. J Biomed Mater Res. 2000;50(3):365-374.
28. Nakamura H, Herzenberg LA, Bai J, etal. Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis. Proc Natl Acad Sci U S A. 2001;98(26):15143-15148.
29. Hirasawa N, Ohtsu H, Watanabe T, Ohuchi K. Enhancement of neutrophil infiltration in histidine decarboxylase-deficient mice. Immunology. 2002;107(2):217-221.
30. Bouma G, Nikolic T, Coppens JM, etal. NOD mice have a severely impaired ability to recruit leukocytes into sites of inflammation. Eur J Immunol. 2005;35(1):225-235.
31. Merinen M, Irjala H, Salmi M, Jaakkola I, Hanninen A, Jalkanen S. Vascular adhesion protein-1 is involved in both acute and chronic inflammation in the mouse. Am J Pathol. 2005;166(3):793-800.
32. Delano DL, Montesinos MC, Desai A, etal. Genetically based resistance to the antiinflammatory effects of methotrexate in the air-pouch model of acute inflammation. Arthritis Rheum. 2005;52(8):2567-2575.
33. Teixeira CR, Teixeira MJ, Gomes RB, etal. Saliva from Lutzomyia longipalpis induces CC chemokine ligand 2/monocyte chemoattractant protein-1 expression and macrophage recruitment. J Immunol. 2005;175(12):8346-8353.
34. Oostingh GJ, Casals E, Italiani P, etal. Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects. Part Fibre Toxicol. 2011;8(1):8.
35. Dobrovolskaia MA, McNeil SE. Immunological properties of engineered nanomaterials. Nat Nanotechnol. 2007;2(8):469-478.
36. Dobrovolskaia MA, Germolec DR, Weaver JL. Evaluation of nanoparticle immunotoxicity. Nat Nanotechnol. 2009;4(7):411-444.
37. Yoshida K, Koshino T, Saito T, Takagi T. Augmentation of anti-tumor effects of methotrexate by distilled water on Dunn osteosarcoma in mouse air pouch. Cancer Lett. 1998;126(2):193-197.
38. Piccard H, Berghmans N, Korpos E, etal. Glycosaminoglycan mimicry by COAM reduces melanoma growth through chemokine induction and function. Int J Cancer. 2012;131(4):E425-E436.
39. Vandooren J, Geurts N, Martens E, Van den Steen PE, Opdenakker G. Zymography methods for visualizing hydrolytic enzymes. Nat Methods. 2013;10(3):211-220.
40. Opdenakker G, Van den Steen PE, Van Damme J. Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol. 2001;22(10): 571-579.
41. Descamps FJ, Martens E, Opdenakker G. Analysis of gelatinases in complex biological fluids and tissue extracts. Lab Invest. 2002;82(11): 1607-1608.
42. Vandooren J, Van den Steen PE, Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): The next decade. Crit Rev Biochem Mol Biol. 2013;48(3): 222-272.
43. Li S, Starckx S, Martens E, etal. Myeloid cells are tunable by a polyanionic polysaccharide derivative and co-determine host rescue from lethal virus infection. J Leukoc Biol. 2010;88(5):1017-1029.